Approaches and challenges in cancer immunotherapy pathways.

Abstract

Cancer immunotherapy is an effective with critical approaches in the treatment of oncological patients. Whilst numerous research and clinical trials are underway to develop endogenous immunotherapy approaches, it is necessary to focus on fundamental issues and identify barriers to basic clinical progress. Addressing these challenges and the new pathways will require researchers and clinicians to join forces to accelerate the understanding of the complex interactions between cancer and the immune system and focus resources on developing better treatments for patients.